Editorial Podcasts

Claire Riches highlights inefficiencies in the current drug approval process, while outlining the role of payers and insurers in shifting toward data-driven approval framework.

Renier Brentjens, MD, PhD outlines the evolution of the space, while offering ways to boost patient access to these treatments.

Tracy Lopez uncovers the fundamentals pertaining to third-party logistics providers.

Donald Prentiss discusses the value of these pharmacies, especially during shortages.

Vibhu Tewary offers insight on this market segment, including a behind-the-scenes of what goes into designing a report.

Nicholas Saraceno offers an overview of the legislation and how it impacts the pharma supply chain.

Rob Sobie outlines the importance of supply chain transparency for the benefit of patients.

Steve Silvestro explains the value of artificial intelligence in launch plans, benefits to integrating DTC and HCP marketing strategies, and more.

Chris Williams expands on the services that a third-party logistics (3PL) partner should offer, while sharing ways to alleviate standard supply chain issues.

Peter Ax provides insight as to industry’s lack of supply, along with how to mitigate these issues.

Mark Bouck discusses PharmAlliance’s latest acquisitions, while reiterating its goals surrounding health economics and outcomes research.

Chip Davis recaps the organization’s Distribution Management Conference and addresses distributors’ preparedness for DSCSA implementation.

Allen Jacques explains the history behind medications’ lack of supply, while offering ways to help alleviate their impact.

Brandon Newman joins The Pharmaceutical Commerce Podcast to discuss the evolving role of PBMs, including the importance of drug price transparency.

Rob Besse offers a breakdown of the third-party logistics (3PL) process, including lessons that these providers have learned coming out of the pandemic.

In this video interview with Associate Editor Miranda Schmalfuhs, Dr. Jo Varshney, CEO & Founder of VeriSIMLife, discusses how artificial intelligence and machine learning can assist in the drug shortage problem.

Dave DeJean provides his expert insight on lessons he’s learned from his plethora of time in the industry, along with an outlook on where the pharma supply chain stands in adhering to the Drug Supply Chain Security Act (DSCSA).

Camille Lee discusses the impact of commercial availability of Bimzelx for the treatment of moderate-to-severe plaque psoriasis in adults, along with the value of patient assistance/affordability programs.

Pharma Commerce editor takes a look back at 2023's impressionable editorial content.

Raphael Chin Fo Sieeuw offers his insight on how to address the sector’s most prominent issues, including how to limit the industry’s carbon footprint.

Jason Cook uncovers ways in which pharma companies can plan for weather-related challenges that may arise.

In this PC Podcast episode, Susanne Katus discusses the increasing number of regulations impacting both pharma and biotech companies.

How these sets of requirements were developed, and the future outlook on track-and-trace over the next decade.

Non-profit executive details ways to ensure supply chain resilience during emergencies.

How these applications—combined with artificial intelligence, machine learning, and natural language processing—influence workflows.

How to leverage today’s logistics technology for safe and reliable results.

The challenges that come with gathering patient information, and how to successfully overcome these obstacles

Lessons learned around commercializing new products in this niche sector

Ways the sector has grown over the years, and how it will continue to adapt in the future

Understanding markets, influencers, and patients through better stakeholder engagement and faster analysis